Non-Current Assets
Deferred Tax Assets
Boston Scientific Deferred Tax Assets increased by 7.6% to $3.95B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 7.5%, from $3.68B to $3.95B. Over 5 years (FY 2020 to FY 2025), Deferred Tax Assets shows a downward trend with a -2.7% CAGR.
Analysis
StatementBalance Sheet Statement
SectionNon-Current Assets
CategoryRisk
SignalContext dependent
VolatilityModerate
First reportedQ4 2019
Last reportedQ1 2026May 1, 2026
How to read this metric
Changes often reflect shifts in tax planning, changes in tax laws, or the utilization of prior-year tax losses.
Detailed definition
These are assets that arise from temporary differences between the book value of assets and liabilities and their tax ba...
Peer comparison
Standard accounting item; comparability depends on the tax jurisdictions in which the company operates.
Metric ID:
non_current_assets_deferred_income_tax_assets_netHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $4.04B | $4.05B | $4.14B | $4.1B | $4.06B | $4.02B | $3.94B | $3.9B | $3.87B | $3.84B | $3.84B | $3.79B | $3.8B | $3.82B | $3.66B | $3.68B | $3.78B | $3.67B | $3.68B | $3.95B |
| QoQ Change | — | +0.3% | +2.3% | -1.0% | -1.0% | -1.0% | -1.9% | -1.1% | -0.9% | -0.6% | +0.0% | -1.3% | +0.2% | +0.4% | -4.2% | +0.6% | +2.8% | -2.9% | +0.2% | +7.6% |
| YoY Change | — | — | — | — | +0.6% | -0.8% | -4.8% | -4.9% | -4.8% | -4.4% | -2.6% | -2.8% | -1.7% | -0.6% | -4.8% | -3.1% | -0.6% | -3.9% | +0.5% | +7.5% |
Range$3.66B – $4.14B
CAGR-0.4%
Avg YoY Growth-1.9%
Median YoY Growth-2.7%
Current Streak2 quarters growth
Deferred Tax Assets at Other Companies
Frequently Asked Questions
- What is Boston Scientific's deferred tax assets?
- Boston Scientific (BSX) reported deferred tax assets of $3.95B in Q1 2026.
- How has Boston Scientific's deferred tax assets changed year-over-year?
- Boston Scientific's deferred tax assets increased by 7.5% year-over-year, from $3.68B to $3.95B.
- What is the long-term trend for Boston Scientific's deferred tax assets?
- Over 5 years (2020 to 2025), Boston Scientific's deferred tax assets has grown at a -2.7% compound annual growth rate (CAGR), from $4.21B to $3.68B.
- What does deferred tax assets mean?
- Future tax savings that the company expects to benefit from based on past accounting or tax events.